Skip to main content

XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE)

NDC 51662-1405 · HF Acquisition Co LLC, DBA HealthFirst

Generic nameXYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE)
Dosage formINJECTION, SOLUTION
RouteEPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL
Active ingredient(s)LIDOCAINE HYDROCHLORIDE ANHYDROUS, EPINEPHRINE BITARTRATE
Strength.005; 10 mg/mL; mg/mL
Pharmacologic classAdrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
Marketing categoryNDA

Packages

51662-1405-1 — 30 mL in 1 VIAL, SINGLE-DOSE (51662-1405-1)

51662-1405-3 — 25 POUCH in 1 CASE (51662-1405-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1405-2) / 30 mL in 1 VIAL, SINGLE-DOSE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

51004-1010 — Articaine Hydrochloride and Epinephrine, 51004-1040 — Articaine Hydrochloride and Epinephrine, 51004-2105 — Lidocaine Hydrochloride and Epinephrine Bitartrate, 51004-4175 — Articaine Hydrochloride and Epinephrine, 51004-4185 — Articaine Hydrochloride and Epinephrine, 51004-5801 — prilocaine hcl and epinephrine, 51004-6620 — Articaine Hydrochloride and Epinephrine, 51004-6625 — Articaine Hydrochloride and Epinephrine, 51662-1397 — SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE), 51662-1399 — BUPIVACAINE HCI AND EPINEPHRINE, 51662-1412 — LIDOCAINE HCI AND EPINEPHRINE WITH EPINEPHRINE, 51662-1505 — LIDOCAINE HCI AND EPINEPHRINE, 51662-1506 — LIDOCAINE HCI AND EPINEPHRINE, 51662-1550 — XYLOCAINE-MPF WITH EPI, 51662-1587 — XYLOCAINE (LIDOCAINE HCl ), 51662-1590 — XYLOCAINE, 51662-1591 — XYLOCAINE, 51662-1604 — LIDOCAINE HCl, 51662-1622 — XYLOCAINE, 51662-1644 — XYLOCAINE MPF, +144 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.